Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dodwell

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
BMJ (Clinical Research Ed.)|August 27, 2025
Patients need information on the risk of second cancer after early breast cancerMairead MacKenzie, Hilary Stobart, David Dodwell, et al.
The Breast Journal|January 31, 2012
Issues in the management of occult neoplasia in breast reduction surgeryJonathan White, Philip Turton, David Dodwell, et al.
Cancer Treatment Reviews|April 26, 2005
The causes and treatment of bone loss associated with carcinoma of the breastJames Lester, David Dodwell, Eugene McCloskey, et al.
The British Journal of Radiology|July 3, 2025
Understanding global variation in breast cancer mortalityMarwa M A Elbasheer, David Dodwell, Toral Gathani
BMJ (Clinical Research Ed.)|June 13, 2023
Risk of breast cancer death after a diagnosis of early invasive breast cancerMairead MacKenzie, Hilary Stobart, David Dodwell, et al.
Journal of Medical Imaging and Radiation Oncology|October 26, 2018
Axillary conservation in women with 1-2 sentinel node-positive breast cancer: Further research is neededFrances K Duane, David Dodwell, Boon H Chua
The Lancet. Oncology|March 7, 2018
Neoadjuvant chemotherapy for early breast cancer - Author's replyPaul McGale, David Dodwell, Carolyn Taylor, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 3, 2015
Radiological and Pathological Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Brief Literature ReviewTejal Parekh, David Dodwell, Nisha Sharma, et al.
Open Research Europe|July 2, 2024
Chemotherapy use and outcomes in patients with stage III or IV small-cell lung cancer in relation to age: An analysis of the English Systemic Anti-Cancer Treatment (SACT) datasetSophie Pilleron, Eva Ja Morris, David Dodwell, et al.
Breast (Edinburgh, Scotland)|September 1, 2024
Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancerLuqi Chen, Stuart A McIntosh, Siddharth Tyagi, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
BMJ (Clinical Research Ed.)|August 27, 2025
Patients need information on the risk of second cancer after early breast cancerMairead MacKenzie, Hilary Stobart, David Dodwell, et al.
The Breast Journal|January 31, 2012
Issues in the management of occult neoplasia in breast reduction surgeryJonathan White, Philip Turton, David Dodwell, et al.
Cancer Treatment Reviews|April 26, 2005
The causes and treatment of bone loss associated with carcinoma of the breastJames Lester, David Dodwell, Eugene McCloskey, et al.
The British Journal of Radiology|July 3, 2025
Understanding global variation in breast cancer mortalityMarwa M A Elbasheer, David Dodwell, Toral Gathani
BMJ (Clinical Research Ed.)|June 13, 2023
Risk of breast cancer death after a diagnosis of early invasive breast cancerMairead MacKenzie, Hilary Stobart, David Dodwell, et al.
Journal of Medical Imaging and Radiation Oncology|October 26, 2018
Axillary conservation in women with 1-2 sentinel node-positive breast cancer: Further research is neededFrances K Duane, David Dodwell, Boon H Chua
The Lancet. Oncology|March 7, 2018
Neoadjuvant chemotherapy for early breast cancer - Author's replyPaul McGale, David Dodwell, Carolyn Taylor, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 3, 2015
Radiological and Pathological Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Brief Literature ReviewTejal Parekh, David Dodwell, Nisha Sharma, et al.
Open Research Europe|July 2, 2024
Chemotherapy use and outcomes in patients with stage III or IV small-cell lung cancer in relation to age: An analysis of the English Systemic Anti-Cancer Treatment (SACT) datasetSophie Pilleron, Eva Ja Morris, David Dodwell, et al.
Breast (Edinburgh, Scotland)|September 1, 2024
Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancerLuqi Chen, Stuart A McIntosh, Siddharth Tyagi, et al.
Pageof 12